Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
03/2012
03/01/2012WO2012026495A1 Novel hydantoin derivative and medicinal agent comprising same as active ingredient
03/01/2012WO2012026491A1 Pluripotent stem cell cardiomyocyte differentiation-promoting agent
03/01/2012WO2012025164A1 Hydroxamate-based inhibitors of deacetylases
03/01/2012WO2012025055A1 Methods and kits for predicting the risk of diabetes associated complications using genetic markers and arrays
03/01/2012WO2011161537A3 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof
03/01/2012WO2011143457A3 Compositions and methods for treating or preventing atrial fibrillation
03/01/2012WO2011113027A3 Npp1 fusion proteins
03/01/2012WO2011109731A3 Arylfluorophosphate inhibitors of intestinal apical membrane sodium/phosphate co-transport
03/01/2012WO2011098582A3 Novel crystalline forms of ivabradine hydrochloride
03/01/2012WO2011069038A3 Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
03/01/2012US20120053510 Treatment of Cardiac Arrhythmia by Modification of Neuronal Signaling Through Fat Pads of the Heart
03/01/2012US20120053247 Method of improving cardiovascular health
03/01/2012US20120053242 Compositions rich in omega-3 fatty acids with a low content in phytanic acid
03/01/2012US20120053228 Splice-region antisense composition and method
03/01/2012US20120053227 miR-33 INHIBITORS AND USES THEREOF
03/01/2012US20120053218 Triazole derivatives as vasopressin-receptor inhibitors for treating cardiac insufficiency
03/01/2012US20120053214 The little molecule compound which used for promoting the stem cells hyperplasia and the use thereof
03/01/2012US20120053199 Noscapine and analogs and methods related thereto
03/01/2012US20120053197 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
03/01/2012US20120053189 Btk inhibitors for the treatment of immune mediated conditions
03/01/2012US20120053186 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
03/01/2012US20120053180 Cyclohexane analogues as gpr119 agonists
03/01/2012US20120053179 Rho-Kinase Inhibitors
03/01/2012US20120053176 Adenosine a3 receptor modulating compounds and methods of use thereof
03/01/2012US20120053168 Fused benzoazepines as neuronal nicotinic acetylcholine receptor ligands
03/01/2012US20120053167 Triazine Derivatives as Kinase Inhibitors
03/01/2012US20120053166 4-Oxadiazol-2-YL-Indazoles as Inhibitors of P13 Kinases
03/01/2012US20120053164 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
03/01/2012US20120053163 Steroids as Agonists for FXR
03/01/2012US20120053159 Isotopologues of lenalidomide
03/01/2012US20120053158 Preparation of an acetyl salicylic acid/glutamic acid complex for oral administration
03/01/2012US20120053156 Compositions and methods for loop diuretics with consistent bioavailability
03/01/2012US20120053149 Thiazole derivatives and their use as p2y12 receptor antagonists
03/01/2012US20120053147 Thiazolopyrimidinone derivatives as pi3 kinase inhibitors
03/01/2012US20120053125 Phosphatase inhibitor protein-1 as a regulator of cardiac function
03/01/2012US20120053123 Natriuretic polypeptides having mutations within their disulfide rings
03/01/2012US20120053114 Method
03/01/2012US20120053113 MANUFACTURE OF INTER-ALPHA-INHIBITOR (IaIp) FROM PLASMA
03/01/2012US20120052292 Novel medical device coatings
03/01/2012US20120052138 Composition comprising green tea extract
03/01/2012US20120052132 Compositions and methods for treatment of body weight conditions
03/01/2012US20120052130 Gpr 119 modulators
03/01/2012US20120052128 Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions
03/01/2012US20120052104 Polypeptides and Antibacterial or Antiseptic Use of Same
03/01/2012US20120052097 Therapeutic peptide-polymer conjugates, particles, compositions, and related methods
03/01/2012US20120052096 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
03/01/2012US20120052088 Pneumococcal vaccine and uses thereof
03/01/2012US20120052070 Compositions and methods of use for binding molecules to dickkopf-1 or dickkopf-4 or both
03/01/2012US20120052068 Autophilic antibodies and method of making the same
03/01/2012US20120052056 Composition for improving blood circulation containing fermented tea, and pharmaceutical and health-food compositions comprising the same
03/01/2012US20120052051 Method of treating diabetes - related vascular complications
03/01/2012US20120052049 Systemic, Allogenic Stem Cell Therapies For Treatment of Diseases in Animals
03/01/2012US20120052047 Use of probiotic strain gm-080 in treating cardiac inflammation and apoptosis
03/01/2012US20120052045 Compositions and methods for modulating ischemic injury
03/01/2012US20120052007 Peripheral blood sparc binding antibodies and uses thereof
03/01/2012US20120052005 Combination therapy to improve drug efficiency
03/01/2012DE102010060693A1 Verwendung des probiotischen Stamms GM-080 bei der Behandlung von Herzentzündungen und Apoptosis The use of the probiotic strain, GM-080 in the treatment of cardiac inflammation and apoptosis
03/01/2012CA2842181A1 Bone marrow derived cd271 precursor cells for cardiac repair
03/01/2012CA2808225A1 Compositions and methods for cardiac therapy
03/01/2012CA2807830A1 Treatment of hypertension and/or prevention or treatment of heart failure in a mammal receiving anti-coagulant therapy
03/01/2012CA2807738A1 Hydroxamate-based inhibitors of deacetylases
02/2012
02/29/2012EP2423203A1 Crystal of benzoxazinone compound
02/29/2012EP2423194A1 NOVEL THYROID HORMONE beta RECEPTOR AGONIST
02/29/2012EP2421859A1 Thiazole derivatives and their use as p2y12 receptor antagonists
02/29/2012EP2421828A2 Piperidine derivatives as inhibitors of renin
02/29/2012EP2421528A1 Compounds, compositions and methods comprising 1,3,4-oxadiazole derivatives
02/29/2012EP2421364A1 Use of guanethidine for treating hypertension by local vascular delivery
02/29/2012EP2123649B1 3-pyrrolo-cyclohexylene-2-dihydro-indolinone derivatives and uses thereof
02/29/2012EP1669350B1 Piperidine derivatives
02/29/2012EP1572725B1 Chi-conotoxin peptides having a n-terminal pyroglutamic acid
02/29/2012EP1532153B1 Azepinoindole and pyridoindole derivatives as pharmaceutical agents
02/29/2012CN202151439U 一种方便服用的麝香保心丸 A convenient taking HMP
02/29/2012CN1972713B Pharmaceutical composition for treating or preventing cardiac dysfunction
02/29/2012CN102365275A Carboxamide compounds and methods for using the same
02/29/2012CN102365269A Novel therapeutic agent for cognitive impairment
02/29/2012CN102363628A Protein with cardiac muscle cell apoptosis resisting function, preparation method and application thereof
02/29/2012CN102363028A Formula and method for treating and combined diseases of lung channel and heart channel by using traditional Chinese medicine
02/29/2012CN102363027A Formula of Chinese medicines, and method for treating combined heart channel and stomach channel tissue diseases
02/29/2012CN102363016A Traditional Chinese medicine composite dripping core pills and preparation method thereof
02/29/2012CN102363003A Formula of Chinese medicines and method for treating combined kidney channel and heart channel tissue diseases
02/29/2012CN102362984A A Chinese patent medicine for curing toxic erythema
02/29/2012CN102362982A Thrombus-preventing traditional Chinese medicine preparation used in apoplexy tendency, and preparation method thereof
02/29/2012CN102362980A Chinese medicinal formula and method for treating spleen channel and heart channel complicating disease
02/29/2012CN102362971A Traditional Chinese medicine for treating coronary disease, preparation method of active chemical ingredients thereof and preparation
02/29/2012CN102362914A Chinese medicinal gels for preventing and treating phlebitis
02/29/2012CN102362905A Method for preparing capsules for removing stasis and unblocking channels
02/29/2012CN102362883A Preparation, quality control method and application of composition of active ingredients of bitter herb
02/29/2012CN102362881A Method for preparing ginkgo and American ginseng preparation
02/29/2012CN102362876A Chinese redwood bark extract, preparation method thereof and purpose thereof
02/29/2012CN102362865A Compound preparation containing benidipine hydrochloride and valsartan and application thereof
02/29/2012CN102178790B Suppository for treating internal hemorrhoids and combined hemorroids
02/29/2012CN102100833B Drug composition for treating heart cerebrovascular diseases as well as preparation method and application thereof
02/29/2012CN102028712B Method for preparing enteric capsules by taking leech as raw material
02/29/2012CN101972244B Preparation method and application of Parabarium huaitingii Chun et Tsiang condensed tannin extract
02/29/2012CN101879198B Method for identification of Xindakang preparation
02/29/2012CN101829071B Aliskiren liposome tablet
02/29/2012CN101785800B Traditional Chinese medicine combination for hepatopathy treatment
02/29/2012CN101780078B Compound preparation of telmisartan and amlodipine and preparation method thereof
02/29/2012CN101723960B Benzopyran zofuran compound as well as preparation method and application thereof
02/29/2012CN101679309B Novel pyrimidine compound having dibenzylamine structure, and medicine comprising the compound
1 ... 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 ... 1595